Abstract The current paradigm considers the study of non‐communicable diseases (NCDs), which are the main causes of mortality, as individual disorders. Nevertheless, this conception is being solidly challenged by numerous remarkable studies. The clear fact that the mortality, by virtually all NCDs, tends to cluster at old ages (with the exception of congenital malformations and certain types of cancer, among a few others); makes us intuitive to assume that the common convergence mechanism that exponentially increases mortality by almost all NCDs in older ages is cell aging. Moreover, when we study NCDs, we are not analyzing which disorders cause the mortality of the populations, rather that which disorders kill us before others do, because the aging of the individuals causes inevitably their death by one cause or another. This is not a defeatist perspective, but a challenging and efficient one. These intuitive assumptions have been supported by studies from the pathophysiologic, epidemiologic, and genetic fields, leading to the affirmation that, as NCDs share genetic and pathophysiological mechanisms (derived from mostly the same risk factors), they should no longer be considered independently. Those studies should make us reconsider our current conceptions of studying NCDs as individual disorders, and to hypothesize about a paradigm that would consider most NCDs (cancer, neurological pathologies, cardiovascular diseases, type II diabetes mellitus, chronic respiratory diseases, osteoarthritis, and osteoporosis, among others) different manifestations of the same process: the cell aging.
{"title":"A pathological convergence theory for <scp>non‐communicable</scp> diseases","authors":"Alicia Padrón‐Monedero","doi":"10.1002/agm2.12273","DOIUrl":"https://doi.org/10.1002/agm2.12273","url":null,"abstract":"Abstract The current paradigm considers the study of non‐communicable diseases (NCDs), which are the main causes of mortality, as individual disorders. Nevertheless, this conception is being solidly challenged by numerous remarkable studies. The clear fact that the mortality, by virtually all NCDs, tends to cluster at old ages (with the exception of congenital malformations and certain types of cancer, among a few others); makes us intuitive to assume that the common convergence mechanism that exponentially increases mortality by almost all NCDs in older ages is cell aging. Moreover, when we study NCDs, we are not analyzing which disorders cause the mortality of the populations, rather that which disorders kill us before others do, because the aging of the individuals causes inevitably their death by one cause or another. This is not a defeatist perspective, but a challenging and efficient one. These intuitive assumptions have been supported by studies from the pathophysiologic, epidemiologic, and genetic fields, leading to the affirmation that, as NCDs share genetic and pathophysiological mechanisms (derived from mostly the same risk factors), they should no longer be considered independently. Those studies should make us reconsider our current conceptions of studying NCDs as individual disorders, and to hypothesize about a paradigm that would consider most NCDs (cancer, neurological pathologies, cardiovascular diseases, type II diabetes mellitus, chronic respiratory diseases, osteoarthritis, and osteoporosis, among others) different manifestations of the same process: the cell aging.","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"95 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135725939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jieyu He, Yanjiao Wang, Junkun Zhan, Shuang Li, Yuqing Ni, Wu Huang, Limin Long, Pan Tan, Yi Wang, Youshuo Liu
Abstract Objective To investigate the relationship between icariin and the osteoblastic differentiation of vascular smooth muscle cells (VSMCs) and the signal pathway involved. Methods We applied a universally accepted calcification model of VSMCs induced by β glycerophosphate. Then the VSMCs calcification was observed by treatment with icariin and/or inhibitors of estrogen receptors (ERs) and p38‐mitogen‐activated protein kinase (MAPK) signaling. Results Icariin inhibited osteoblastic differentiation and mineralization of VSMCs due to decreased ALP activity and Runx2 expression. Further study demonstrated that icariin exerted this suppression effect through activating p38‐MAPK but not extracellular‐regulated kinase, JNK or Akt. An inhibitor of p38‐MAPK partially reversed the inhibitory effects of icariin on osteoblastic differentiation. Interestingly, treatment of VSMCs with an ER antagonist ICI182780 and a selective ERα receptor antagonist PPT attenuated icariin‐mediated inhibition effect of VSMCs calcification, associated with suppression of p38‐MAPK phosphorylation. Conclusions Icariin inhibited the osteoblastic differentiation of VSMCs, and that the inhibitory effects were mediated by p38‐MAPK pathways through ERα.
{"title":"Icariin attenuates the calcification of vascular smooth muscle cells through <scp>ERα</scp> – <scp>p38MAPK</scp> pathway","authors":"Jieyu He, Yanjiao Wang, Junkun Zhan, Shuang Li, Yuqing Ni, Wu Huang, Limin Long, Pan Tan, Yi Wang, Youshuo Liu","doi":"10.1002/agm2.12267","DOIUrl":"https://doi.org/10.1002/agm2.12267","url":null,"abstract":"Abstract Objective To investigate the relationship between icariin and the osteoblastic differentiation of vascular smooth muscle cells (VSMCs) and the signal pathway involved. Methods We applied a universally accepted calcification model of VSMCs induced by β glycerophosphate. Then the VSMCs calcification was observed by treatment with icariin and/or inhibitors of estrogen receptors (ERs) and p38‐mitogen‐activated protein kinase (MAPK) signaling. Results Icariin inhibited osteoblastic differentiation and mineralization of VSMCs due to decreased ALP activity and Runx2 expression. Further study demonstrated that icariin exerted this suppression effect through activating p38‐MAPK but not extracellular‐regulated kinase, JNK or Akt. An inhibitor of p38‐MAPK partially reversed the inhibitory effects of icariin on osteoblastic differentiation. Interestingly, treatment of VSMCs with an ER antagonist ICI182780 and a selective ERα receptor antagonist PPT attenuated icariin‐mediated inhibition effect of VSMCs calcification, associated with suppression of p38‐MAPK phosphorylation. Conclusions Icariin inhibited the osteoblastic differentiation of VSMCs, and that the inhibitory effects were mediated by p38‐MAPK pathways through ERα.","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136358858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Objective: To investigate the involvement of HOX transcript antisense RNA (HOTAIR) in the injury of renal tubular epithelial cells induced by high glucose. Results: In high glucose‐induced HK‐2 cells, the expression of HOTAIR was upregulated, resulting in suppressed cell proliferation. Meanwhile, HOTAIR upregulates the expression of pro‐apoptotic proteins Bax and cleaved caspase‐3, while downregulating the expression of the anti‐apoptotic protein Bcl‐2. Luciferase reporter assays revealed that HOTAIR could target miR‐126‐5p. Additionally, it was found that the PI3K/Akt signaling pathway serves as a downstream target of miR‐126‐5p. Knockdown of HOTAIR relieved apoptosis, whereas further inhibition of miR‐126‐5p led to apoptosis in HK‐2 cells. Conclusions: HOTAIR plays a regulatory role in mediating high glucose‐induced injuries in HK‐2 cells, specifically affecting apoptosis and cell viability, via the miR‐126‐5p/PI3K/Akt signaling pathway.
{"title":"<scp>LncRNA HOX transcript antisense RNA</scp> mediates hyperglycemic‐induced injury in the renal tubular epithelial cell via the <scp>miR‐126‐5pAkt</scp> axis","authors":"Qiong Jiang, Ting Yang, Yan Zou, Mingjie He, Qingchun Li, Xiaohui Chen, Aimin Zhong","doi":"10.1002/agm2.12266","DOIUrl":"https://doi.org/10.1002/agm2.12266","url":null,"abstract":"Abstract Objective: To investigate the involvement of HOX transcript antisense RNA (HOTAIR) in the injury of renal tubular epithelial cells induced by high glucose. Results: In high glucose‐induced HK‐2 cells, the expression of HOTAIR was upregulated, resulting in suppressed cell proliferation. Meanwhile, HOTAIR upregulates the expression of pro‐apoptotic proteins Bax and cleaved caspase‐3, while downregulating the expression of the anti‐apoptotic protein Bcl‐2. Luciferase reporter assays revealed that HOTAIR could target miR‐126‐5p. Additionally, it was found that the PI3K/Akt signaling pathway serves as a downstream target of miR‐126‐5p. Knockdown of HOTAIR relieved apoptosis, whereas further inhibition of miR‐126‐5p led to apoptosis in HK‐2 cells. Conclusions: HOTAIR plays a regulatory role in mediating high glucose‐induced injuries in HK‐2 cells, specifically affecting apoptosis and cell viability, via the miR‐126‐5p/PI3K/Akt signaling pathway.","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135537840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Objective In this study, our objective is to propose various models to estimate healthy life year lost (HLYL) and healthy life expectancy (HLE) in India. Methods The HLYL and HLE were estimated and further these estimates were compared with the direct life table method and the World Health Organization (WHO) method. From the mortality perspective, we have developed a log‐logistic model for estimating the parameter (bx), which is characterized by HLYL. The results were compared with other models, such as the Gompertz and Weibull model. Here, we have also obtained the HLE by subtracting HLYL from the total life expectancy. Results The result shows an increasing trend of HLYL among the male, female, and the total population in India. Conclusion From the log‐logistic model, the HLYL was estimated as 8.79 years, 8.36 years, and 9.38 years for the total, male, and female populations, respectively, in India during 2019.
{"title":"Statistical modeling and estimating number of healthy life years lost and healthy life expectancy in India, 2000–2019","authors":"Diptismita Jena, Prafulla Kumar Swain, Manas Ranjan Tripathy, Pravat Kumar Sarangi","doi":"10.1002/agm2.12269","DOIUrl":"https://doi.org/10.1002/agm2.12269","url":null,"abstract":"Abstract Objective In this study, our objective is to propose various models to estimate healthy life year lost (HLYL) and healthy life expectancy (HLE) in India. Methods The HLYL and HLE were estimated and further these estimates were compared with the direct life table method and the World Health Organization (WHO) method. From the mortality perspective, we have developed a log‐logistic model for estimating the parameter (bx), which is characterized by HLYL. The results were compared with other models, such as the Gompertz and Weibull model. Here, we have also obtained the HLE by subtracting HLYL from the total life expectancy. Results The result shows an increasing trend of HLYL among the male, female, and the total population in India. Conclusion From the log‐logistic model, the HLYL was estimated as 8.79 years, 8.36 years, and 9.38 years for the total, male, and female populations, respectively, in India during 2019.","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135538212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bernadine Teng, Sjaan R. Gomersall, Anna L. Hatton, Asaduzzaman Khan, Sandra G. Brauer
Abstract Objectives Using a multi‐ethnic Asian population, this study assessed adherence to prescribed home exercise programs, explored factors predicting adherence, and evaluated whether home exercise adherence was associated with physical activity. Methods A prospective cohort study was conducted in 68 older adults (aged ≥65 years) from two geriatric outpatient clinics in Singapore, who were receiving tailored home exercises while undergoing 6 weeks of outpatient physical therapy for falls prevention. Adherence was measured as the percentage of prescribed sessions completed. Predictor variables included sociodemographic factors, clinical characteristics, intervention‐specific factors, and physical and psychosocial measures. Multivariable linear regressions were performed to develop a model that best predicted adherence to prescribed exercise. Physical activity levels, measured by accelerometry, were analyzed by cross‐sectional univariate analysis at 6 weeks. Results The mean adherence rate was 65% (SD 34.3%). In the regression model, the number of medications [ B = 0.360, 95% CI (0.098–0.630)], social support for exercising [ B = 0.080, 95% CI (0.015–0.145)], and self‐efficacy for exercising [ B = −0.034, 95% CI (−0.068–0.000)] significantly explained 31% ( R 2 = 0.312) of the variance in exercise adherence. Older adults with better adherence took more steps/day at 6 weeks [ B = 0.001, 95% CI (0.000–0.001)]. Conclusions Low adherence to home exercise programs among older adults in Singapore, emphasizing the need for improvement. Counterintuitively, older adults with more medications, lower exercise self‐efficacy, but with greater social support demonstrated higher adherence. Addressing unmet social support needs is crucial for enhancing adherence rates and reducing fall risks.
{"title":"Predictors of real‐world adherence to prescribed home exercise in older patients with a risk of falling: A prospective observational study","authors":"Bernadine Teng, Sjaan R. Gomersall, Anna L. Hatton, Asaduzzaman Khan, Sandra G. Brauer","doi":"10.1002/agm2.12270","DOIUrl":"https://doi.org/10.1002/agm2.12270","url":null,"abstract":"Abstract Objectives Using a multi‐ethnic Asian population, this study assessed adherence to prescribed home exercise programs, explored factors predicting adherence, and evaluated whether home exercise adherence was associated with physical activity. Methods A prospective cohort study was conducted in 68 older adults (aged ≥65 years) from two geriatric outpatient clinics in Singapore, who were receiving tailored home exercises while undergoing 6 weeks of outpatient physical therapy for falls prevention. Adherence was measured as the percentage of prescribed sessions completed. Predictor variables included sociodemographic factors, clinical characteristics, intervention‐specific factors, and physical and psychosocial measures. Multivariable linear regressions were performed to develop a model that best predicted adherence to prescribed exercise. Physical activity levels, measured by accelerometry, were analyzed by cross‐sectional univariate analysis at 6 weeks. Results The mean adherence rate was 65% (SD 34.3%). In the regression model, the number of medications [ B = 0.360, 95% CI (0.098–0.630)], social support for exercising [ B = 0.080, 95% CI (0.015–0.145)], and self‐efficacy for exercising [ B = −0.034, 95% CI (−0.068–0.000)] significantly explained 31% ( R 2 = 0.312) of the variance in exercise adherence. Older adults with better adherence took more steps/day at 6 weeks [ B = 0.001, 95% CI (0.000–0.001)]. Conclusions Low adherence to home exercise programs among older adults in Singapore, emphasizing the need for improvement. Counterintuitively, older adults with more medications, lower exercise self‐efficacy, but with greater social support demonstrated higher adherence. Addressing unmet social support needs is crucial for enhancing adherence rates and reducing fall risks.","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135536668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elderly patients with depressive disorder always have complex and diverse symptoms, and are mostly combined with chronic physical conditions. This case report presents a case of vortioxetine usage in a 67-year-old male patient with major depressive disorder and accompanied by multiple physical conditions. In elderly people, depression mainly affects those with chronic physical diseases. Such as coronary heart disease, hypertension and diabetes. Vortioxetine is a novel antidepressant with multimodal activity that has two different types of pharmacologic targets: serotonin receptors and transporters that have been approved for the treatment of major depressive disorder (MDD).1 Both short-term and long-term clinical trials indicated that vortioxetine is effective and safe in patients with MDD. Other effects include improved cognitive function and quality of life in patients with MDD.2 However, no studies have reported the efficacy of vortioxetine in elderly patients with depression combined with chronic physical diseases so far. We hope that this case can provide some references for the use of antidepressants in the clinical practice. The patient, a 67-year-old male, retired worker, presented with gradual poor mood, decreased interest, and excessive concerns for more than 3 years, and was admitted to the psychiatry department of the second Xiangya hospital on February 24, 2021. The patient reported that following the placement of a heart stent in September 2018, he experienced a gradual onset of symptoms including poor mood, listlessness, decreased interest, hypologia, hypokinesia, preference for solitude, excessive concerns about health, and emotional instability. Besides, the patient often complained of dizziness and poor memory. At first, his self-care ability was fine, thus, his family did not pay attention to him, regarding his conditions as “a bad mood”. Later, he often had negative words and felt that it was meaningless to live. He first went to outpatient clinic in July 2020, and was considered the diagnosis of “depressive state.” He was recommended to take 10 mg qd of escitalopram and 0.5 mg bid of lorazepam. In further consultation in August, he claimed that his mood had improved, but decrease in interest remained significant and he did not care for housework. According to the doctor's advice, escitalopram tablets were increased to 15 mg qd and lorazepam tablets 0.5 mg bid. Since then the patient adhered to medication, but symptoms remained unstable. He switched to 1 tablet of flupentixol-melitracen in September 2020, but the response was still not good. For further treatment, he sought hospitalization on February 24, 2021. Since the onset of the disease, his appetite was fair, and both urination and stool were normal. The patient had a history of coronary atherosclerotic heart disease (CHD) and was implanted with a stent in September 2018. He had been taking aspirin enteric coated tablets 100 mg qd, perindopril tert butylamine tablets 4 m
{"title":"Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report","authors":"Xiaoman Wang, Xiaoqian Ma, Yicheng Long, Guowei Wu","doi":"10.1002/agm2.12268","DOIUrl":"https://doi.org/10.1002/agm2.12268","url":null,"abstract":"Elderly patients with depressive disorder always have complex and diverse symptoms, and are mostly combined with chronic physical conditions. This case report presents a case of vortioxetine usage in a 67-year-old male patient with major depressive disorder and accompanied by multiple physical conditions. In elderly people, depression mainly affects those with chronic physical diseases. Such as coronary heart disease, hypertension and diabetes. Vortioxetine is a novel antidepressant with multimodal activity that has two different types of pharmacologic targets: serotonin receptors and transporters that have been approved for the treatment of major depressive disorder (MDD).1 Both short-term and long-term clinical trials indicated that vortioxetine is effective and safe in patients with MDD. Other effects include improved cognitive function and quality of life in patients with MDD.2 However, no studies have reported the efficacy of vortioxetine in elderly patients with depression combined with chronic physical diseases so far. We hope that this case can provide some references for the use of antidepressants in the clinical practice. The patient, a 67-year-old male, retired worker, presented with gradual poor mood, decreased interest, and excessive concerns for more than 3 years, and was admitted to the psychiatry department of the second Xiangya hospital on February 24, 2021. The patient reported that following the placement of a heart stent in September 2018, he experienced a gradual onset of symptoms including poor mood, listlessness, decreased interest, hypologia, hypokinesia, preference for solitude, excessive concerns about health, and emotional instability. Besides, the patient often complained of dizziness and poor memory. At first, his self-care ability was fine, thus, his family did not pay attention to him, regarding his conditions as “a bad mood”. Later, he often had negative words and felt that it was meaningless to live. He first went to outpatient clinic in July 2020, and was considered the diagnosis of “depressive state.” He was recommended to take 10 mg qd of escitalopram and 0.5 mg bid of lorazepam. In further consultation in August, he claimed that his mood had improved, but decrease in interest remained significant and he did not care for housework. According to the doctor's advice, escitalopram tablets were increased to 15 mg qd and lorazepam tablets 0.5 mg bid. Since then the patient adhered to medication, but symptoms remained unstable. He switched to 1 tablet of flupentixol-melitracen in September 2020, but the response was still not good. For further treatment, he sought hospitalization on February 24, 2021. Since the onset of the disease, his appetite was fair, and both urination and stool were normal. The patient had a history of coronary atherosclerotic heart disease (CHD) and was implanted with a stent in September 2018. He had been taking aspirin enteric coated tablets 100 mg qd, perindopril tert butylamine tablets 4 m","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135878196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}